Correction: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

  • Jia Li1Email author,

    Affiliated with

    • Xiangjie Kong1Email author,

      Affiliated with

      • Junfeng Zhang1,

        Affiliated with

        • Qifeng Luo1,

          Affiliated with

          • Xiaoyu Li1 and

            Affiliated with

            • Lin Fang1Email author

              Affiliated with

              Cancer Cell International201313:17

              DOI: 10.1186/1475-2867-13-17

              Received: 20 February 2013

              Accepted: 20 February 2013

              Published: 21 February 2013

              Correction

              After publication of this article [1], the authors noted an error in Figure 1. The labelling of normal tissues and cancer tissues was inverted. Please see Figure 1 for the corrected version. The authors apologise for any inconvenience this has caused.
              http://static-content.springer.com/image/art%3A10.1186%2F1475-2867-13-17/MediaObjects/12935_2013_406_Fig1_HTML.jpg
              Figure 1

              miR-26b is relatively downregulated in breast cancer.

              Authors’ Affiliations

              (1)
              Department of Breast and Thyroid, Shanghai Tenth People’s Hospital

              References

              1. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int 2013, 13:7.PubMedView Article

              Copyright

              © Li et al.; licensee BioMed Central Ltd. 2013

              This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

              Advertisement